Desk› Chemicals› Titan Biotech Ltd
Titan Biotech Ltd
Filing rhythm · 60 trading days
7 filings · 3 material · busiest 2026-08-13
What it files
Filings
7 in the window
-
14 August 2026
Newspaper PublicationNewspaper Publication
Newspaper publication of the Unaudited Financial Results (Standalone & Consolidated) for quarter ended June 30, 2026
Company Update / Newspaper Publication View filing →
-
13 August 2026
ResultsUnaudited Financial Results For Quarter Ended June 2026
Unaudited Financial Results along with the limited review report from the statutory Auditor of the Company for the quarter ended June 2026
Result / Financial Results View filing →
-
13 August 2026
Board OutcomeBoard Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026
Board Meeting Outcome For Unaudited Financial Results For Quarter Ended June 30, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
5 August 2026
Board MeetingBoard Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30, 2026.
Titan Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the standalone and consolidated ....
Board Meeting / Board Meeting View filing →
-
6 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
25 June 2026
Press ReleasePress Release / Media Release (Revised)
Intimation for loss of shares by shareholder which have already been transferred earlier to Investor Education Protection Fund.
Company Update / Press Release / Media Release (Revised) View filing →
-
23 June 2026
Trading WindowClosure of Trading Window
Closure of trading window
Insider Trading / SAST / Closure of Trading Window View filing →